Global Preterm Birth Prevention and Management Market Insights, Forecast to 2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Preterm Birth Prevention and Management Market Insights, Forecast to 2034
Preterm birth is among the prevalent public health concerns all over the world and has become the primary cause of mortality in children aging below 5 years. To curb the alarming situation, governments including, the Food and Drug Administration (FDA), are showing immediacy in approving drugs for preterm birth prevention and management.
Market Analysis and InsightsGlobal Preterm Birth Prevention and Management Market
Global Preterm Birth Prevention and Management market is expected to reach to US$ 1457 million in 2024, with a positive growth of %, compared with US$ 1412 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Preterm Birth Prevention and Management industry is evaluated to reach US$ 1760.1 million in 2029. The CAGR will be 3.2% during 2024 to 2029.
The preterm birth prevention and management market is driven by the increasing awareness about the adverse effects of preterm birth on neonatal health and the growing emphasis on maternal and child healthcare. Preterm birth, defined as delivery before 37 weeks of pregnancy, poses significant risks to both the baby and the mother. Advances in medical research and technology have led to the development of various interventions and treatments to prevent and manage preterm birth, such as progesterone supplements, cervical cerclage, and improved prenatal care. Additionally, rising healthcare expenditure and government initiatives aimed at reducing preterm birth rates are contributing to the market's growth. However, challenges include the complex and multifactorial nature of preterm birth, making it difficult to predict and prevent in all cases. The effectiveness of interventions can vary depending on individual patient factors, leading to a need for personalized treatment approaches. Furthermore, access to quality healthcare and specialized facilities can be a challenge in some regions, impacting the implementation of effective preterm birth prevention and management strategies. As healthcare systems continue to evolve and research in this field progresses, the preterm birth prevention and management market is expected to witness advancements that improve maternal and neonatal outcomes.
Report Covers
This report presents an overview of global Preterm Birth Prevention and Management market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Preterm Birth Prevention and Management market with multiple angles. Items like regional revenue from 2018 to 2029 and companies’ revenue and gross margin from 2018 to 2024 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Companies, Type, Application and Regions Listed in the Report
AMAG Pharmaceuticals
Ferring Pharmaceutical
Teva
Allergan
AbbVie
Aurobindo Pharma
Bayer
Viatris
Pfizer
Merck & Co
Novartis
Sanofi
Segment by Type
Progesterone Therapy
Corticosteroid Therapy
Tocolytics Therapy
Antihypertensive Therapy
Magnesium Sulfate Therapy
Other
Hospital
Drugs Stores
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2029
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2029 globally
Chapter 5Product revenue analysis by application from 2018 to 2029 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2029 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product revenue analysis by type and application from 2018 to 2029 in Europe. Product revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product revenue analysis by type and application from 2018 to 2029 in China. Product revenue analysis of China from 2018 to 2029
Chapter 9Product revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Companies’ outline, covering company’s basic information, major business, Preterm Birth Prevention and Management introduction, etc. Preterm Birth Prevention and Management Revenue and Gross Margin of each company from 2018 to 2024
Chapter 12Mr Accuracy reports Conclusions of Preterm Birth Prevention and Management
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports
Market Analysis and InsightsGlobal Preterm Birth Prevention and Management Market
Global Preterm Birth Prevention and Management market is expected to reach to US$ 1457 million in 2024, with a positive growth of %, compared with US$ 1412 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Preterm Birth Prevention and Management industry is evaluated to reach US$ 1760.1 million in 2029. The CAGR will be 3.2% during 2024 to 2029.
The preterm birth prevention and management market is driven by the increasing awareness about the adverse effects of preterm birth on neonatal health and the growing emphasis on maternal and child healthcare. Preterm birth, defined as delivery before 37 weeks of pregnancy, poses significant risks to both the baby and the mother. Advances in medical research and technology have led to the development of various interventions and treatments to prevent and manage preterm birth, such as progesterone supplements, cervical cerclage, and improved prenatal care. Additionally, rising healthcare expenditure and government initiatives aimed at reducing preterm birth rates are contributing to the market's growth. However, challenges include the complex and multifactorial nature of preterm birth, making it difficult to predict and prevent in all cases. The effectiveness of interventions can vary depending on individual patient factors, leading to a need for personalized treatment approaches. Furthermore, access to quality healthcare and specialized facilities can be a challenge in some regions, impacting the implementation of effective preterm birth prevention and management strategies. As healthcare systems continue to evolve and research in this field progresses, the preterm birth prevention and management market is expected to witness advancements that improve maternal and neonatal outcomes.
Report Covers
This report presents an overview of global Preterm Birth Prevention and Management market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Preterm Birth Prevention and Management market with multiple angles. Items like regional revenue from 2018 to 2029 and companies’ revenue and gross margin from 2018 to 2024 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Companies, Type, Application and Regions Listed in the Report
By Company
AMAG Pharmaceuticals
Ferring Pharmaceutical
Teva
Allergan
AbbVie
Aurobindo Pharma
Bayer
Viatris
Pfizer
Merck & Co
Novartis
Sanofi
Segment by Type
Progesterone Therapy
Corticosteroid Therapy
Tocolytics Therapy
Antihypertensive Therapy
Magnesium Sulfate Therapy
Other
Segment by Application
Hospital
Drugs Stores
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2029
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2029 globally
Chapter 5Product revenue analysis by application from 2018 to 2029 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2029 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product revenue analysis by type and application from 2018 to 2029 in Europe. Product revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product revenue analysis by type and application from 2018 to 2029 in China. Product revenue analysis of China from 2018 to 2029
Chapter 9Product revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Companies’ outline, covering company’s basic information, major business, Preterm Birth Prevention and Management introduction, etc. Preterm Birth Prevention and Management Revenue and Gross Margin of each company from 2018 to 2024
Chapter 12Mr Accuracy reports Conclusions of Preterm Birth Prevention and Management
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports